Designing Tech Transfer for Reality - Joe Brady
Show notes
In this episode, tech transfer expert and lecturer Joe Brady explains why most projects are “already late on day one” and unpacks the real causes of delay across the product lifecycle, from stability studies and PPQ batches to warehouses, materials, and analytical methods. He contrasts innovator to innovator with innovator to CMO transfers, shares hard‑won lessons on auditing, scaling legacy products, and soft‑skill pitfalls with CMOs, and explores how knowledge management, digitisation, and AI will reshape how pharma approaches tech transfer.
Contact us at: [email protected]
This episode is sponsored by STERIS.